Developments in Tryptophan and Serotonin Metabolism

Volume 527 of the series Advances in Experimental Medicine and Biology pp 105-112

Expression of The Kynurenine Pathway Enzymes in Human Microglia and Macrophages

  • Gilles J. Guillemin
  • , Danielle G. Smith
  • , George A. Smythe
  • , Patricia J. Armati
  • , George J. Brew

* Final gross prices may vary according to local VAT.

Get Access


There is good evidence that the kynurenine pathway (KP) and one of its products, quinolinic acid (QUIN) play a role in the pathogenesis of neurological diseases. Monocytic cells are known to be the major producers of QUIN. However, macrophages have the ability to produce approximately 20 to 30-fold more QUIN than microglia. The molecular origin of this difference has not been clarified yet. Using unstimulated and IFN-y-stimulated cultures of human fcetal microglia and adult macrophages, we assayed mRNA expression of 8 key enzymes of the KP using RT-PCR and QUIN production using GC-MS. We found that after stimulation with IFN-y microglia producedde novo20-fold less QUIN than macrophages. This quantitative difference in the ability to produce QUIN appears to be associated with a lower expression of 3 important enzymes of the KP in microglia: indoleamine 2,3-dioxygenase (IDO), kynureninase (KYNase) and kynurenine hydroxylase (KYN(OH)ase). These results suggest that activated infiltrating macrophages are the most potent QUIN producers during brain inflammatory diseases with playing a lesser role.